Luke Boyd

Luke Boyd, CG (ASCP)

Manager, Cytogenetics Lab

View Bio >
Sarah McCabe

Sarah McCabe, B.S.

Manager, Genomics Lab

View Bio >
Danielle Galipeau

Danielle Galipeau, B.S.

Manager, Front Office and BioLibrary

View Bio >
Joanna Pucilowska

Joanna Pucilowska, MS, PhD

Interim Knight Diagnostics Co-Director,
Director, Immune Monitoring and Cancer Omics Services
Scientific Partnerships and Business Development, Oncology

View Bio >
Kate Rice

Kate Rice,

Supervisor, Histopathology Shared Resource Laboratory

View Bio >

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More